Nova Financial’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Other funds holding MYGN
Nova Financial's MYGN Position: Q3 2026 in Review
Nova Financial opened a new position in Myriad Genetics (MYGN) in Q3 2026: 25 shares worth $108. The stake represents ﹤0.01% of the portfolio and ranks #834 among its holdings.
175 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.
- Nova Financial held 25 shares of Myriad Genetics worth $108 as of Q3 2026.
- Myriad Genetics was a new Nova Financial position in Q3 2026.
- Myriad Genetics made up ﹤0.01% of Nova Financial's portfolio in Q3 2026, its #834 holding.
- 175 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.
Based on Nova Financial's 13F filing for Q3 2026, filed 4 Nov 2026.